BOPA-PRUK Research Award – NOW OPEN for Applications 2021

The BOPA-PRUK research award

This award provides pharmacy professionals who are new to research with the extra incentive to get their research career started.

Pharmacy Research UK (PRUK) and the British Oncology Pharmacy Association (BOPA) have collaborated together for 5 years to provide this opportunity to oncology and haematology pharmacy colleagues.  Multiple people have already benefited from this generous award.

This year, the award is worth £20,000. This allows us to offer the whole amount to a single person or to break the award down to offer more people smaller amounts of a minimum of £5,000. The funding can be used to partly or fully fund a research project.

Any member of the pharmacy team can apply. Projects must be related to the provision of oncology or haematology pharmacy services directly impacting patient care and benefit.

For further information please refer to the PRUK website. We recommend you read through all the material contained within the PRUK website before starting your application.

PRUK offer a mentoring scheme available to pharmacy professionals who wish to seek guidance and support for developing their research skills. If you think you could benefit from this please refer to the PRUK webpage.

Visit back soon to hear from some of our previous winners to give you tips and ideas for your research project.

 

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article